Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RDH11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RNMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CINP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYL12A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF207 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDM5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIPF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3C2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIF1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGDIA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on